NZ514329A - Polynucleotide and deduced amino acid sequences from stromal cells - Google Patents

Polynucleotide and deduced amino acid sequences from stromal cells

Info

Publication number
NZ514329A
NZ514329A NZ514329A NZ51432900A NZ514329A NZ 514329 A NZ514329 A NZ 514329A NZ 514329 A NZ514329 A NZ 514329A NZ 51432900 A NZ51432900 A NZ 51432900A NZ 514329 A NZ514329 A NZ 514329A
Authority
NZ
New Zealand
Prior art keywords
leu
gly
ser
val
ala
Prior art date
Application number
NZ514329A
Other languages
English (en)
Inventor
Lorna Strachan
Matthew Sleeman
Nevin Abernethy
Rene Onrust
Krishanand D Kumble
James Greg Murison
Original Assignee
Genesis Res & Dev Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Res & Dev Corp Ltd filed Critical Genesis Res & Dev Corp Ltd
Publication of NZ514329A publication Critical patent/NZ514329A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ514329A 1999-03-25 2000-02-18 Polynucleotide and deduced amino acid sequences from stromal cells NZ514329A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27626899A 1999-03-25 1999-03-25
US09/383,586 US6242419B1 (en) 1999-03-25 1999-08-26 Compositions isolated from stromal cells and methods for their use
PCT/NZ2000/000015 WO2000058463A1 (en) 1999-03-25 2000-02-18 Polynucleotide and deduced amino acid sequences from stromal cells

Publications (1)

Publication Number Publication Date
NZ514329A true NZ514329A (en) 2003-07-25

Family

ID=26957887

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ514329A NZ514329A (en) 1999-03-25 2000-02-18 Polynucleotide and deduced amino acid sequences from stromal cells

Country Status (9)

Country Link
US (1) US6242419B1 (enExample)
EP (1) EP1163334A4 (enExample)
JP (1) JP2002539827A (enExample)
CN (1) CN1358228A (enExample)
AU (1) AU782974B2 (enExample)
CA (1) CA2368477A1 (enExample)
HK (1) HK1048137A1 (enExample)
NZ (1) NZ514329A (enExample)
WO (1) WO2000058463A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132252A1 (en) * 1997-06-16 2002-09-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030143676A1 (en) * 1999-03-25 2003-07-31 Genesis Research And Development Corporation Limited Fibroblast growth factor receptors and methods for their use
AU5887700A (en) * 1999-10-19 2001-04-30 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
US6743907B1 (en) * 1999-10-19 2004-06-01 Lexicon Genetics Incorporated Human proteins and polynucleotides encoding the same
US7348162B2 (en) * 2000-03-22 2008-03-25 Amgen Inc. Nucleic acids encoding fibroblast growth factor receptor-like proteins and uses thereof
WO2001092495A2 (en) * 2000-05-26 2001-12-06 Millennium Pharmaceuticals, Inc. A human lysyl ixodase (47765) and uses thereof
US6812002B2 (en) * 2000-08-30 2004-11-02 Pfizer Inc. Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
JP2002272470A (ja) * 2001-03-21 2002-09-24 Takashi Nakamura リジルオキシダーゼ関連タンパク質をコードする核酸
CA2489145A1 (en) 2002-05-24 2003-12-04 Takeda Pharmaceutical Company Limited Insulin-sensitizing agent
CA2504443A1 (en) * 2002-10-30 2004-05-13 Pointilliste, Inc. Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
US20040241748A1 (en) * 2003-02-10 2004-12-02 Dana Ault-Riche Self-assembling arrays and uses thereof
US20070275872A1 (en) * 2003-10-28 2007-11-29 Cooper Garth J Peptides with Anti-Obesity Activity and Other Related Uses
US20050095648A1 (en) * 2003-10-30 2005-05-05 Mario Geysen Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
US20090297479A1 (en) * 2008-03-28 2009-12-03 Kiyoshi Ariizumi Dc-hil conjugates for treatment of t-cell disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009327A2 (en) * 1999-07-28 2001-02-08 Genentech, Inc. Method of preventing the injury or death of retinal cells and treating ocular diseases
WO1999063088A2 (en) 1998-06-02 1999-12-09 Genentech, Inc. Membrane-bound proteins and nucleic acids encoding the same
AU4688499A (en) 1998-10-23 2000-05-15 Human Genome Sciences, Inc. Fibroblast growth factor receptor-5
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2495200A (en) * 1999-03-08 2000-09-28 Genentech Inc. Compositions and methods for the treatment of tumor
AU3774300A (en) * 1999-06-02 2000-12-18 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU5907800A (en) * 1999-06-30 2001-01-31 Millennium Pharmaceuticals, Inc. Membrane-associated and secreted proteins and uses thereof
EP1242443A4 (en) * 1999-12-23 2005-06-22 Nuvelo Inc NEW NUCLEIC ACIDS AND POLYPEPTIDES
CA2400034A1 (en) * 2000-02-17 2001-08-23 Incyte Genomics, Inc. Human kinases

Also Published As

Publication number Publication date
AU2702100A (en) 2000-10-16
WO2000058463A1 (en) 2000-10-05
JP2002539827A (ja) 2002-11-26
CA2368477A1 (en) 2000-10-05
EP1163334A1 (en) 2001-12-19
EP1163334A4 (en) 2004-07-28
US6242419B1 (en) 2001-06-05
AU782974B2 (en) 2005-09-15
CN1358228A (zh) 2002-07-10
HK1048137A1 (zh) 2003-03-21

Similar Documents

Publication Publication Date Title
AU733322B2 (en) Novel VEGF-like factor
AU782974B2 (en) Polynucleotide and deduced amino acid sequences from stromal cells
US6380362B1 (en) Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
CN100558745C (zh) 同种排斥反应的特异性抑制
US20040034192A1 (en) Human proteins having hyprophobic domains and dnas encoding these proteins
EP1039801A1 (en) 207 human secreted proteins
US20020102542A1 (en) Polypeptide, cdna encoding the polypeptide, and use of the both
US20030143676A1 (en) Fibroblast growth factor receptors and methods for their use
CA2327259A1 (en) Human transcriptional regulator molecules
US20020065394A1 (en) Secreted proteins and polynucleotides encoding them
US20040058849A1 (en) Fibroblast growth factor receptors and methods for their use
US6797271B2 (en) Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US6706869B1 (en) Map kinase phosphatases and polynucleotides encoding them
US7700724B2 (en) Isolated INSP 163 protein
CA2260754C (en) Novel vegf-like factor
JP2000512506A (ja) 新規化合物
CA2418395C (en) Protein induced by homogeneous blood transfusion and dna encoding the same
IL175569A (en) Cytokine antagonist molecules
CA2452260C (en) Novel variants and exons of the glyt1 transporter
US20030113720A1 (en) cDNAs expressed in adipocyte differentiation
US20020165350A1 (en) Novel polypeptide, a method of producing it, and utility of the polypeptide
US20030017545A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
US20030008356A1 (en) Novel polypeptide, a cDNA encoding the same, and use of it
MXPA01013265A (es) Proteina citoplasmica que liga calcio inducida por un trauma de cabeza.
US20030176649A1 (en) Vmglom gene and its mutations causing disorders with a vascular component

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
S38A Application for proceedings under section 38 (amendment of specification with leave of commissioner)

Free format text: REASON BY WAY OF DISCLAIMER